Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration statement for a proposed initial public offering. It has applied for the ticker "AGMX" on NASDAQ.
The share count and the pricing of this IPO are not yet determined, but it listed the "up to"amount as $86.3 million for filing purposes. All shares in the offering will be sold by the company rather than insiders.
The company lists J.P. Morgan Securities as the sole book-runner andalso lists Deutsche Bank Securities as co-lead manager. Co-managersare listed as Pacific Growth Equities and Robert W. Baird & Co.
The company designs, develops, manufactures and markets a fullyintegrated molecular diagnostics system called the INFINITI™ thatautomates the discrete processes of genetic testing performed byclinical laboratories. It already holds trademarks of INFINITI™,BioFilmChip™, Intellipac™ and Qmatic™, and it received market approvalfrom the FDA for its INFINITI™ system.
Jon C. Ogg
July 25, 2008
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
